Marshall, J., Hwang, J., Eskens, F. A. L. M., Burger, H., Malik, S., Uttenreuther-Fischer, M., . . . Lewis, N. L. (2012). A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors. Springer US.
Chicago Style CitationMarshall, John, et al. A Phase I, Open-label, Dose Escalation Study of Afatinib, in a 3-week-on/1-week-off Schedule in Patients With Advanced Solid Tumors. Springer US, 2012.
MLA CitationMarshall, John, et al. A Phase I, Open-label, Dose Escalation Study of Afatinib, in a 3-week-on/1-week-off Schedule in Patients With Advanced Solid Tumors. Springer US, 2012.
Warning: These citations may not always be 100% accurate.